Quanterix to Participate in Upcoming Investor Conferences

About this update from Quanterix Corporation

BILLERICA, Mass., February 26, 2026 --( BUSINESS WIRE )-- Quanterix Corporation (Nasdaq: QTRX) , a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that its executive leadership team will participate in the following investor conferences in March: 46th Annual TD Cowen Healthcare Conference Format: Fireside chat and one-on-one meetings Date: Wednesday, March 4, 2026 Time: 11:50 am ET Webcast: Click here Leerink Global Healthcare Conference 2026 Format: Fireside chat and one-on-one meetings Date: Monday, March 9, 2026 Time: 1:00 pm ET Webcast: Click here Interested parties may access a live and recorded webcast of the fireside chats on the Investors section of the company’s website at www.quanterix.com . About Quanterix Quanterix is a global leader in ultra-sensitive biomarker detection, enabling breakthroughs in disease research, diagnostics, and drug development. Its proprietary Simoa® technology delivers industry-leading sensitivity, allowing researchers to detect and quantify biomarkers in blood and other fluids at concentrations far below traditional limits. With approximately 6,000 peer-reviewed publications, Quanterix has been a trusted partner to the scientific community for nearly two decades. In 2025, Quanterix acquired Akoya Biosciences, The Spatial Biology Company®, adding multiplexed tissue imaging with single-cell resolution to its portfolio and 1,396 installed instruments. Together, the combined company offers a uniquely integrated platform that connects biology across blood and tissue—advancing precision medicine from discovery to diagnostics. Learn more at www.quanterix.com . View source version on businesswire.com: https://www.businesswire.com/news/home/20260226120026/en/ Contacts Media [email protected] Investor Relations Joshua Young [email protected]

View stock analysis, news, and events for Quanterix Corporation